TR199903211T2 - Azasteroitler içeren çözeltiler. - Google Patents

Azasteroitler içeren çözeltiler.

Info

Publication number
TR199903211T2
TR199903211T2 TR1999/03211T TR9903211T TR199903211T2 TR 199903211 T2 TR199903211 T2 TR 199903211T2 TR 1999/03211 T TR1999/03211 T TR 1999/03211T TR 9903211 T TR9903211 T TR 9903211T TR 199903211 T2 TR199903211 T2 TR 199903211T2
Authority
TR
Turkey
Prior art keywords
present
azasteroids
solutions containing
invention describes
another aspect
Prior art date
Application number
TR1999/03211T
Other languages
English (en)
Turkish (tr)
Inventor
Frank Parr Alan
Catherine Rizzolio Michele
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of TR199903211T2 publication Critical patent/TR199903211T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TR1999/03211T 1997-08-19 1998-08-17 Azasteroitler içeren çözeltiler. TR199903211T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9717444.5A GB9717444D0 (en) 1997-08-19 1997-08-19 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
TR199903211T2 true TR199903211T2 (xx) 2000-04-21

Family

ID=10817633

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03211T TR199903211T2 (xx) 1997-08-19 1998-08-17 Azasteroitler içeren çözeltiler.

Country Status (10)

Country Link
EP (1) EP1005346A2 (xx)
JP (1) JP2002511100A (xx)
KR (1) KR20010014079A (xx)
CN (1) CN1263466A (xx)
AU (1) AU8979698A (xx)
BR (1) BR9810285A (xx)
CA (1) CA2295023A1 (xx)
GB (1) GB9717444D0 (xx)
TR (1) TR199903211T2 (xx)
WO (1) WO1999008684A2 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS6633A (is) * 2002-11-22 2004-05-23 Omega Farma Ehf. Samsetningar af fínasteríð töflum
CZ300438B6 (cs) * 2003-11-25 2009-05-20 Pliva Hrvatska D.O.O. Zpusob prípravy orální pevné lékové formy s okamžitým uvolnováním úcinné látky obsahující jako úcinnou látku polymorfní formu finasteridu
EP1704162A1 (de) * 2004-01-02 2006-09-27 PharmaCon Forschung und Beratung GmbH Verfahren zur herstellung von 1,2-ungesätigten azasteroiden
EP2050436A1 (en) 2007-12-21 2009-04-22 Siegfried Generics International AG Pharmaceutical composition containing dutasteride
DE102008059201A1 (de) * 2008-11-27 2010-06-02 GÖPFERICH, Achim, Prof. Dr. In situ präzipitierende Arzneistofflösungen
KR101055412B1 (ko) * 2010-11-19 2011-08-08 (주)비씨월드제약 두타스테라이드를 포함하는 자가유화 에멀젼 조성물 및 이의 제조방법
CN103169712B (zh) * 2011-12-20 2017-10-27 重庆华邦制药有限公司 提高生物利用度的度他雄胺制剂及其制备方法
JP2015516441A (ja) * 2012-05-18 2015-06-11 ルオダ ファーマ ピーティーワイ リミテッド 液体配合剤
CN103479595B (zh) * 2012-06-13 2015-08-26 成都国弘医药有限公司 一种含有度他雄胺的软胶囊
WO2014002015A1 (en) 2012-06-25 2014-01-03 Ranbaxy Laboratories Limited Pharmaceutical composition comprising dutasteride
CN103830201A (zh) * 2012-11-20 2014-06-04 重庆医药工业研究院有限责任公司 一种度他雄胺液体软胶囊
EP2949319A1 (en) 2014-05-26 2015-12-02 Galenicum Health S.L. Pharmaceutical compositions comprising an active agent
JP7017938B2 (ja) * 2018-01-15 2022-02-09 森下仁丹株式会社 ３－オキソ－４－アザアンドロスト－１－エン－１７－カルボン酸誘導体含有製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516768A (en) * 1990-03-16 1996-05-14 Smithkline Beecham Corporation Uncompetitive inhibition of steroid and 5α-reductose
US5300294A (en) * 1990-06-27 1994-04-05 Smithkline Beecham Corporation Method of treating prostatic adenocarcinoma
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
EP0859617A1 (en) * 1995-09-27 1998-08-26 Merck & Co., Inc. Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors
WO1998025463A1 (en) * 1996-12-09 1998-06-18 Merck & Co., Inc. Methods and compositions for preventing and treating bone loss

Also Published As

Publication number Publication date
AU8979698A (en) 1999-03-08
BR9810285A (pt) 2000-09-12
JP2002511100A (ja) 2002-04-09
GB9717444D0 (en) 1997-10-22
CA2295023A1 (en) 1999-02-25
KR20010014079A (ko) 2001-02-26
CN1263466A (zh) 2000-08-16
EP1005346A2 (en) 2000-06-07
WO1999008684A2 (en) 1999-02-25
WO1999008684A3 (en) 1999-06-10

Similar Documents

Publication Publication Date Title
DE3484779D1 (de) Pharmazeutische mittel.
TR199903211T2 (xx) Azasteroitler içeren çözeltiler.
TR200000517T2 (tr) Piperidinoalkanol-Konjesyon azaltıcıdan oluşan kombinasyona yönelik farmasötik kompozisyon.
TR200101333T2 (tr) Bir ensülin sensitizörü ve başka bir anti-diyabetik maddenin değiştirilmiş salımı için farmasötik terkip.
NZ280610A (en) Soft gelatin-like pharmaceutical carrier: gelled polyethylene glycol and dispersed active agent
PL341054A1 (en) Novel suppositiories containing an active compound being unstable in acid environments
FR2760193B1 (fr) Lipides et complexes de lipides cationiques et de substances actives, notamment pour la transfection de cellules
ID26340A (id) Kapsul ganda dengan penggunaan bahan-bahan aktif dalam berbagai macam pengobatan
TR200100931T2 (tr) Yeni sürekli salınımlı oral formülasyonlar
PL327767A1 (en) Drugs containing known auxiliary substances and an active substance
ES2162922T3 (es) Composicion para administracion colonica de medicamentos.
DE69928085D1 (de) Dosierungsform mit verlängerter wirkstoffabgabe
BR9814592B1 (pt) composto azapolicìclico condensado com arila, composição farmacêutica contendo o mesmo e seu uso na fabricação de um medicamento.
TR200200982T2 (tr) Farmasötik bileşim terkipleri.
TR200100093T2 (tr) Deterjan tableti
DE69631970D1 (de) Archaeoliposome, koenzym q10 enthaltende archaeoliposome und koenzym q10 enthaltende liposome als adjuvans und wirkstoffabgabevehikel
EE05620B1 (et) Omeprasooli mikrograanulid, nende valmistamismeetod ja farmatseutilised preparaadid
DE69813602T2 (de) Venlafaxinhaltiges arzneimittel mit verlängerter wirkstoffabgabe
TR199902175T2 (xx) Parasetamol i�eren yutma tableti.
TR199901413T2 (xx) Eklem iltihab� i�in yeni tedavi.
TR199903209T2 (xx) Farmasötik bileşim.
TR200503846T2 (tr) Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı
TR199802573A3 (tr) Bir etken madde içeren çökelmis silisler.
SE9803272D0 (sv) A drug for cell regeneration
DE3070184D1 (en) Pharmacologically active peptides, their preparation and pharmaceutical compositions containing them